A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Typically when a new drug comes on the market, physicians are conservative about their prescribing habits, but this has not ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

PatchMD, a leading innovator in transdermal nutrient delivery, is excited to announce the launch of its new GLP-1 Support ...